Related Experiment Video
Updated: Mar 12, 2026

Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke
Published on: June 6, 2025
The Effectiveness of Hyperbaric Oxygen Therapy as a Treatment for Postconcussion Symptoms
Insights
Hyperbaric oxygen therapy (HBOT) is not supported by current evidence for treating persistent postconcussion syndrome symptoms. Most studies indicate it is ineffective for concussion recovery.
Area of Science:
- Neurology
- Sports Medicine
- Hyperbaric Medicine
Background:
- Concussions are common, with symptoms like headaches and cognitive impairment persisting as postconcussion syndrome.
- Hyperbaric oxygen therapy (HBOT) is an emerging treatment for these persistent symptoms.
- HBOT has faced both support and criticism regarding its efficacy.
Purpose of the Study:
- To evaluate the effectiveness of HBOT in reducing symptoms for individuals with postconcussion syndrome (symptoms lasting over 3 months).
Main Methods:
- A literature search identified 5 relevant Level 1 studies.
- These studies were critically appraised to determine the clinical effectiveness of HBOT.
Main Results:
- Four of the five Level 1 studies refuted the use of HBOT for postconcussion syndrome.
- One study supported the use of HBOT, but the overall evidence leans against its efficacy.
Conclusions:
- The available evidence suggests that HBOT is not an effective treatment for postconcussion syndrome.
- Further research may be needed, but current findings recommend against its use.
Abstract:
Clinical Scenario: Concussions are a prevalent topic in medicine. Concussion symptoms include headaches, dizziness, nausea, neuropsychiatric symptoms, and cognitive impairments, the persistence of which is referred to as postconcussion syndrome. Hyperbaric oxygen therapy (HBOT) has been proposed and evaluated as an additional treatment of these symptoms. HBOT is an innovative approach that has been considered by many but has received both criticism and acceptance.
Clinical Question:
Is HBOT an effective means of reducing symptoms for individuals suffering from postconcussion syndrome (persistence of symptoms for >3 mo)? Summary of Search: The literature was searched for studies that were relevant to the clinical question. Literature provided 5 level 1 studies that were relevant enough to be considered. Clinical Bottom Line: Based on the research that is available, the authors conclude that there is more evidence to refute the use of HBOT for postconcussion syndrome than to support it. Strength of Recommendation: Four studies disprove the use of HBOT; 1 study supported the use of HBOT. These 5 studies are the same level of evidence (level 1) and provide significant findings in their studies. The strength of this recommendation is a B according to the Centre for Evidence-Based Medicine.
More Related Videos
08:20Simultaneous Application of Transcranial Direct Current Stimulation during Virtual Reality Exposure
Published on: January 18, 2021
04:02Author Spotlight: Developing Precise and Clinically Relevant Models for Studying Secondary Degeneration in Traumatic Optic Neuropathy
Published on: November 29, 2024